[go: up one dir, main page]

AU2001273202A1 - Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury - Google Patents

Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury

Info

Publication number
AU2001273202A1
AU2001273202A1 AU2001273202A AU7320201A AU2001273202A1 AU 2001273202 A1 AU2001273202 A1 AU 2001273202A1 AU 2001273202 A AU2001273202 A AU 2001273202A AU 7320201 A AU7320201 A AU 7320201A AU 2001273202 A1 AU2001273202 A1 AU 2001273202A1
Authority
AU
Australia
Prior art keywords
ascorbic acid
regeneration
injury
salts
promote cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273202A
Inventor
Grazyna Nowak
Ricky Schnellmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Arkansas at Little Rock
Original Assignee
University of Arkansas at Fayetteville
University of Arkansas at Little Rock
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Arkansas at Fayetteville, University of Arkansas at Little Rock filed Critical University of Arkansas at Fayetteville
Publication of AU2001273202A1 publication Critical patent/AU2001273202A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/428—Vitamins, e.g. tocopherol, riboflavin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001273202A 2000-07-05 2001-07-05 Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury Abandoned AU2001273202A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21596000P 2000-07-05 2000-07-05
US60215960 2000-07-05
PCT/US2001/021337 WO2002001954A1 (en) 2000-07-05 2001-07-05 Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury

Publications (1)

Publication Number Publication Date
AU2001273202A1 true AU2001273202A1 (en) 2002-01-14

Family

ID=22805087

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273202A Abandoned AU2001273202A1 (en) 2000-07-05 2001-07-05 Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury

Country Status (3)

Country Link
US (1) US20020019372A1 (en)
AU (1) AU2001273202A1 (en)
WO (1) WO2002001954A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20020557A1 (en) * 2002-03-15 2003-09-15 Acraf USE OF A SALT OF L-ASCORBIC ACID TO PREPARE A PHARMACEUTICAL COMPOSITION FOR TOPICAL OPHTHALMIC USE CAPABLE OF IMPROVING THE LEVEL D
JPWO2005084660A1 (en) * 2004-03-05 2007-08-09 森重 文江 Mitochondrial disease prevention and countermeasures
GB2450477A (en) * 2007-06-18 2008-12-31 Ethicon Inc Stabilized wound dressing
US8034363B2 (en) * 2008-12-11 2011-10-11 Advanced Technologies And Regenerative Medicine, Llc. Sustained release systems of ascorbic acid phosphate
GB2470040A (en) * 2009-05-06 2010-11-10 Systagenix Wound Man Ip Co Bv Wound dressing material comprising N-acetyl cysteine
PL2948003T3 (en) 2013-01-23 2021-01-25 Bottled Science Limited Skin enhancing beverage composition
US20190099295A1 (en) * 2017-09-29 2019-04-04 Johnson & Johnson Consumer Inc. Extensible Dressings
TWI645850B (en) * 2017-10-03 2019-01-01 長庚醫療財團法人林口長庚紀念醫院 Use of ascorbic acid for the preparation of ophthalmic compositions for protecting corneal endothelial cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
EP0282746A1 (en) * 1987-02-19 1988-09-21 Takeda Chemical Industries, Ltd. Method for producing artificial cultured tissue

Also Published As

Publication number Publication date
US20020019372A1 (en) 2002-02-14
WO2002001954A1 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
PL362917A1 (en) New mandelic acid derivatives and their use as throbin inhibitors
AU2001261126A1 (en) Dc to dc converter method and circuitry
HUP0201633A2 (en) Alpha-aminosulphonyl-acetohydroxamic acid derivatives with metalloprotease inhibiting effect, preparation and use thereof
PL328871A1 (en) Substituted derivatives of 4-hydroxyphenyloalcanic acid exhibiting antagonistic activity in respect to ppar-gamma
SI1371647T1 (en) Pyridine-3-carboxylic acid derivatives and their use as intermediates
IL156131A0 (en) Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors
PL1641916T3 (en) Regeneration and repair of neural tissue using postpartum-derived cells
ATE405996T1 (en) REDUCING THE RATIO OF PEAK POWER TO AVERAGE POWER IN A MOBILE COMMUNICATIONS SYSTEM
PT2915534T (en) Pharmaceutical composition for dermal use to treat psoriasis comprising a vitamin d and a corticosteroid
AU2001278046A1 (en) Dc to dc converter and power management system
BR0009158B1 (en) ascorbic acid based topical composition for the treatment of skin damage
PL355998A1 (en) Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
AU1467201A (en) Method and apparatus to provide reductant for NOx
AU2002230836A1 (en) Benzylamine derivatives and their use as thrombin inhibitors
AU2001273202A1 (en) Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury
EE200100514A (en) Inhibitors of LFA-1 binding to ICAMs and their use
AU2002363523A1 (en) Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
AU7958100A (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
AU5693101A (en) New thiochromane derivatives and their use as thrombin inhibitors
AU3694895A (en) Nox destruction in sulphuric acid
AU2001242847A1 (en) Polyphosphate for use in promoting wound healing and scar abatement
AU2002213057A1 (en) Method and system to construct action coordination profiles
AU2003297074A1 (en) Transdermal buprenorphine to treat pain in sickle cell crisis
AU2002358217A1 (en) Improvements in or relating to energy storage devices
SI1259515T1 (en) Thienopyridine derivatives and their use as anti-inflammatory agents